Neovasc Inc. (NVCN) |
|
30.03 0 (0%)
|
04-10 16:00 |
|
Open: |
29.59 |
Pre. Close: |
30.03 |
|
High:
|
30.07 |
Low:
|
29.43 |
|
Volume:
|
1 |
Market Cap:
|
83(M) |
|
|
|
Technical analysis |
as of: 2023-05-05 4:22:22 PM |
|
Short-term rate:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
|
| Target: |
Six months: 35.12 One year: 41.02 |
| Support: |
Support1: 29.43 Support2: 29.04 |
| Resistance: |
Resistance1: 30.06 Resistance2: 35.12 |
| Pivot: |
29.81  |
| Moving Average: |
MA(5): 30.03 MA(20): 29.71
MA(100): 23.41 MA(250): 13.26 |
| MACD: |
MACD(12,26): 0.3  Signal(9): 0.3 |
| Stochastic oscillator: |
%K(14,3): 96 %D(3): 96 |
| RSI: |
RSI(14): 63.9 |
| 52-week: |
High: 30.06 Low: 4.58 |
| Average Vol(K): |
3-Month: 28 (K) 10-Days: 1 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ NVCN ] has closed below upper band by 32.7%. Bollinger Bands are 74.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 51 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
30.1 - 30.25 |
30.25 - 30.37 |
|
Low:
|
29.61 - 29.82 |
29.82 - 29.98 |
|
Close:
|
29.74 - 30.05 |
30.05 - 30.3 |
|
Company Description |
|
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. |
Headline News |
Wed, 12 Apr 2023
Neovasc : Notice of Change in Corporate Structure - Form 6-K - Marketscreener.com
Wed, 05 Apr 2023
NVCN: 3 Stocks to Evade During Earnings Season - StockNews.com
Fri, 31 Mar 2023
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial ... - GlobeNewswire
Mon, 06 Mar 2023
Neovasc Shareholders Approve Acquisition by Shockwave Medical - GlobeNewswire
Wed, 01 Feb 2023
Neovasc Announces German Reimbursement Renewal - GlobeNewswire
Tue, 17 Jan 2023
Neovasc stock soars on takeover deal plus more daily small cap ... - Proactive Investors USA
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
3 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
3.6 (%) |
|
% Held by Institutions
|
7.8 (%) |
|
Shares Short
|
29 (K) |
|
Shares Short P.Month
|
12 (K) |
Stock Financials |
|
EPS
|
-15.07 |
|
EPS Est Next Qtl
|
-0.08 |
|
EPS Est This Year
|
-0.35 |
|
EPS Est Next Year
|
-0.21 |
|
Book Value (p.s.)
|
10.22 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-2 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.93 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-07-01 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
